Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression

収録刊行物

被引用文献 (4)*注記

もっと見る

問題の指摘

ページトップへ